Ben Quah

Dr. Ben Quah is a Research Fellow in the Division of Genome Sciences and Cancer at Australian National University's John Curtin School of Medical Research. He leads the Irradiation Immunity Interaction Laboratory (I-Cube Lab) investigating immune responses to cancer therapies with emphasis on radiation-immunotherapy combinations.

His research combines high-parameter flow cytometry with machine learning approaches to develop diagnostic platforms for cancer subtyping and progression monitoring. Recent work establishes blood-based immune signature analysis for early cancer detection and personalized treatment strategies. The I-Cube Lab focuses on decoding tumor microenvironment changes following radiation exposure to optimize combination therapies.

Quah's translational research includes development of a multiparameter platform for radio-immunotherapy personalization in metastatic colorectal cancer. His work on extracellular histone neutralization explores novel immunomodulatory approaches for inflammatory conditions. With extensive experience in immune profiling and computational analysis, he contributes to projects spanning cancer diagnostics, therapeutic development, and immune monitoring technologies.